419 related articles for article (PubMed ID: 10966936)
1. Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency.
Saito K; Fujigaki S; Heyes MP; Shibata K; Takemura M; Fujii H; Wada H; Noma A; Seishima M
Am J Physiol Renal Physiol; 2000 Sep; 279(3):F565-72. PubMed ID: 10966936
[TBL] [Abstract][Full Text] [Related]
2. Kynurenine pathway enzymes in brain: responses to ischemic brain injury versus systemic immune activation.
Saito K; Nowak TS; Suyama K; Quearry BJ; Saito M; Crowley JS; Markey SP; Heyes MP
J Neurochem; 1993 Dec; 61(6):2061-70. PubMed ID: 8245962
[TBL] [Abstract][Full Text] [Related]
3. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.
Heyes MP; Saito K; Major EO; Milstien S; Markey SP; Vickers JH
Brain; 1993 Dec; 116 ( Pt 6)():1425-50. PubMed ID: 8293279
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of delayed increases in kynurenine pathway metabolism in damaged brain regions following transient cerebral ischemia.
Saito K; Nowak TS; Markey SP; Heyes MP
J Neurochem; 1993 Jan; 60(1):180-92. PubMed ID: 8417138
[TBL] [Abstract][Full Text] [Related]
5. A mechanism for increased quinolinic acid formation following acute systemic immune stimulation.
Saito K; Crowley JS; Markey SP; Heyes MP
J Biol Chem; 1993 Jul; 268(21):15496-503. PubMed ID: 8340378
[TBL] [Abstract][Full Text] [Related]
6. Kynurenine pathway metabolites in cerebrospinal fluid and serum in complex partial seizures.
Heyes MP; Saito K; Devinsky O; Nadi NS
Epilepsia; 1994; 35(2):251-7. PubMed ID: 8156942
[TBL] [Abstract][Full Text] [Related]
7. Tryptophan metabolism along the kynurenine pathway in diet-induced and genetic hypercholesterolemic rabbits.
Allegri G; Ragazzi E; Costa CV; Caparrotta L; Biasiolo M; Comai S; Bertazzo A
Clin Chim Acta; 2004 Dec; 350(1-2):41-9. PubMed ID: 15530458
[TBL] [Abstract][Full Text] [Related]
8. Changes in quinolinic acid production and its related enzymes following D-galactosamine and lipopolysaccharide-induced hepatic injury.
Ohashi H; Saito K; Fujii H; Wada H; Furuta N; Takemura M; Maeda S; Seishima M
Arch Biochem Biophys; 2004 Aug; 428(2):154-9. PubMed ID: 15246871
[TBL] [Abstract][Full Text] [Related]
9. Enzyme activities along the tryptophan-nicotinic acid pathway in alloxan diabetic rabbits.
Ragazzi E; Costa CV; Caparrotta L; Biasiolo M; Bertazzo A; Allegri G
Biochim Biophys Acta; 2002 May; 1571(1):9-17. PubMed ID: 12031285
[TBL] [Abstract][Full Text] [Related]
10. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.
Heyes MP; Saito K; Crowley JS; Davis LE; Demitrack MA; Der M; Dilling LA; Elia J; Kruesi MJ; Lackner A
Brain; 1992 Oct; 115 ( Pt 5)():1249-73. PubMed ID: 1422788
[TBL] [Abstract][Full Text] [Related]
11. Changes in kynurenine pathway metabolism in the brain, liver and kidney of aged female Wistar rats.
Braidy N; Guillemin GJ; Mansour H; Chan-Ling T; Grant R
FEBS J; 2011 Nov; 278(22):4425-34. PubMed ID: 22032336
[TBL] [Abstract][Full Text] [Related]
12. Involvement of the kynurenine pathway in human glioma pathophysiology.
Adams S; Teo C; McDonald KL; Zinger A; Bustamante S; Lim CK; Sundaram G; Braidy N; Brew BJ; Guillemin GJ
PLoS One; 2014; 9(11):e112945. PubMed ID: 25415278
[TBL] [Abstract][Full Text] [Related]
13. Enzyme activities involved in tryptophan metabolism along the kynurenine pathway in rabbits.
Bertazzo A; Ragazzi E; Biasiolo M; Costa CV; Allegri G
Biochim Biophys Acta; 2001 Aug; 1527(3):167-75. PubMed ID: 11479034
[TBL] [Abstract][Full Text] [Related]
14. Peripheral distribution of kynurenine metabolites and activity of kynurenine pathway enzymes in renal failure.
Pawlak D; Tankiewicz A; Matys T; Buczko W
J Physiol Pharmacol; 2003 Jun; 54(2):175-89. PubMed ID: 12832720
[TBL] [Abstract][Full Text] [Related]
15. Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and beta 2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients.
Heyes MP; Brew BJ; Saito K; Quearry BJ; Price RW; Lee K; Bhalla RB; Der M; Markey SP
J Neuroimmunol; 1992 Sep; 40(1):71-80. PubMed ID: 1387655
[TBL] [Abstract][Full Text] [Related]
16. [Enzymes of the kynurenine pathway].
Tankiewicz A; Pawlak D; Buczko W
Postepy Hig Med Dosw; 2001; 55(5):715-31. PubMed ID: 11795205
[TBL] [Abstract][Full Text] [Related]
17. Quinolinic acid formation in immune-activated mice: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(-3-nitrophenyl)thiazol-2yl]-benzenesul fonamide (Ro 61-8048), two potent and selective inhibitors of kynurenine hydroxylase.
Chiarugi A; Moroni F
Neuropharmacology; 1999 Aug; 38(8):1225-33. PubMed ID: 10462134
[TBL] [Abstract][Full Text] [Related]
18. 6-Chloro-D,L-tryptophan, 4-chloro-3-hydroxyanthranilate and dexamethasone attenuate quinolinic acid accumulation in brain and blood following systemic immune activation.
Saito K; Markey SP; Heyes MP
Neurosci Lett; 1994 Sep; 178(2):211-5. PubMed ID: 7824198
[TBL] [Abstract][Full Text] [Related]
19. Species differences in L-tryptophan-kynurenine pathway metabolism: quantification of anthranilic acid and its related enzymes.
Fujigaki S; Saito K; Takemura M; Fujii H; Wada H; Noma A; Seishima M
Arch Biochem Biophys; 1998 Oct; 358(2):329-35. PubMed ID: 9784247
[TBL] [Abstract][Full Text] [Related]
20. Kynurenine pathway enzymes in guinea pigs.
Allegri G; Costa CV; Ragazzi E; Bertazzo A; Biasiolo M
Adv Exp Med Biol; 2003; 527():465-71. PubMed ID: 15206764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
